{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T07:05:25Z","timestamp":1790406325624,"version":"4.1.0"},"reference-count":27,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2002,7,31]],"date-time":"2002-07-31T00:00:00Z","timestamp":1028073600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancer"],"published-print":{"date-parts":[[2002,8,15]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>BACKGROUND<\/jats:title><jats:p>Many patients with colorectal carcinoma develop unresectable metastases confined to the liver that remain the life\u2010limiting component of disease despite best available systemic or regional chemotherapy. In the current study, the authors present their results using vascular isolation and perfusion of the liver for individuals with progressive, unresectable liver metastases from colorectal carcinoma that were refractory to both previous systemic and regional chemotherapy.<\/jats:p><\/jats:sec><jats:sec><jats:title>METHODS<\/jats:title><jats:p>Seven patients with refractory, progressive, unresectable colorectal carcinoma metastases confined to the liver underwent a 60\u2010minute hyperthermic (39\u201340 \u00b0C) isolated hepatic perfusion (IHP) and were followed for toxicity, response, and survival.<\/jats:p><\/jats:sec><jats:sec><jats:title>RESULTS<\/jats:title><jats:p>There was no surgical\u2010 or treatment\u2010related mortality; all patients experienced transient Grade 3\u20134 (according to National Cancer Institute common toxicity criteria) hepatic toxicity. At a median potential follow\u2010up of 16 months, the overall objective radiographic response rate (all partial responses) was 71% (5 of 7 assessable patients). It is interesting to note that two patients who were treated with tumor necrosis factor (TNF) alone demonstrated no response to therapy compared with all five patients who were treated with melphalan and TNF (three patients) or melphalan alone (two patients). For the 5 patients who responded to treatment, the median duration of response was 10 months (range, 10\u201313 months) and in all 7 patients the mean overall survival was 19.7 months (range, 2\u201333 months), including 5 months and 7.5 months, respectively, for the 2 patients treated with TNF alone.<\/jats:p><\/jats:sec><jats:sec><jats:title>CONCLUSIONS<\/jats:title><jats:p>The results of the current study demonstrate that IHP using melphalan with or without TNF has significant antitumor activity in this patient population. IHP deserves continued clinical evaluation as a therapeutic modality for patients with unresectable colorectal carcinoma metastases to the liver. Cancer 2002;95:730\u20136. Published 2002 American Cancer Society.<\/jats:p><jats:p>DOI 10.1002\/cncr.10686<\/jats:p><\/jats:sec>","DOI":"10.1002\/cncr.10686","type":"journal-article","created":{"date-parts":[[2002,10,6]],"date-time":"2002-10-06T08:07:53Z","timestamp":1033891673000},"page":"730-736","source":"Crossref","is-referenced-by-count":18,"title":["Hepatic vascular isolation and perfusion for patients with progressive unresectable liver metastases from colorectal carcinoma refractory to previous systemic and regional chemotherapy"],"prefix":"10.1002","volume":"95","author":[{"suffix":"Jr.","given":"H. Richard","family":"Alexander","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven K.","family":"Libutti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David L.","family":"Bartlett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James F.","family":"Pingpank","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen","family":"Kranda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cynthia","family":"Helsabeck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatiana","family":"Beresnev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2002,7,31]]},"reference":[{"key":"e_1_2_5_2_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200009283431302"},{"key":"e_1_2_5_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(00)02034-1"},{"key":"e_1_2_5_4_2","first-page":"947","article-title":"Update on hepatic intra\u2010arterial chemotherapy","volume":"11","author":"Venook AP","year":"1997","journal-title":"Oncology."},{"key":"e_1_2_5_5_2","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-642-80460-1_1"},{"key":"e_1_2_5_6_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1989.7.11.1646"},{"key":"e_1_2_5_7_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-107-4-459"},{"key":"e_1_2_5_8_2","doi-asserted-by":"publisher","DOI":"10.1097\/00000658-198712000-00001"},{"key":"e_1_2_5_9_2","doi-asserted-by":"publisher","DOI":"10.1001\/archsurg.1990.01410200086013"},{"key":"e_1_2_5_10_2","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/88.5.252"},{"key":"e_1_2_5_11_2","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-0142(19961015)78:8<1639::AID-CNCR1>3.0.CO;2-9"},{"key":"e_1_2_5_12_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2000.18.2.243"},{"key":"e_1_2_5_13_2","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.1998.627"},{"key":"e_1_2_5_14_2","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1200\/JCO.1997.15.4.1432","article-title":"Phase II trial of hepatic arterial infusion of fluorouracil and recombinant human interferon alfa\u20102b for liver metastases of colorectal cancer refractory to systemic fluorouracil and leucovorin","volume":"15","author":"Patt YZ","year":"1997","journal-title":"J Clin Oncol."},{"key":"e_1_2_5_15_2","series-title":"Updates: principles and practice of oncology","first-page":"1","author":"Alexander HR","year":"2001"},{"key":"e_1_2_5_16_2","first-page":"769","volume-title":"Cancer: principles and practice of oncology","author":"Alexander HR","year":"2001"},{"key":"e_1_2_5_17_2","doi-asserted-by":"publisher","DOI":"10.1634\/theoncologist.5-5-416"},{"key":"e_1_2_5_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0039-6060(98)70200-4"},{"key":"e_1_2_5_19_2","doi-asserted-by":"publisher","DOI":"10.1053\/ejso.1998.0623"},{"key":"e_1_2_5_20_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1998.16.4.1479"},{"key":"e_1_2_5_21_2","doi-asserted-by":"publisher","DOI":"10.1067\/msy.2001.110365"},{"key":"e_1_2_5_22_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1072-7515(00)00733-X"},{"key":"e_1_2_5_23_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00801607"},{"key":"e_1_2_5_24_2","first-page":"784","article-title":"Role of tumor necrosis factor (TNF) on toxicity and cytokine production following isolated hepatic perfusion (IHP)","volume":"7","author":"Lans TE","year":"2001","journal-title":"Clin Cancer Res."},{"key":"e_1_2_5_25_2","first-page":"274","article-title":"Hyperthermic isolated limb perfusion with tumor necrosis factor alone for melanoma","volume":"1","author":"Posner MC","year":"1995","journal-title":"Cancer J Sci Am."},{"key":"e_1_2_5_26_2","first-page":"127","volume-title":"Current clinical oncology: regional chemotherapy: clinical research and practice","author":"Alexander HR","year":"1999"},{"key":"e_1_2_5_27_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00182056"},{"key":"e_1_2_5_28_2","doi-asserted-by":"publisher","DOI":"10.1016\/0003-4975(94)90104-X"}],"container-title":["Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fcncr.10686","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/acsjournals.onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/cncr.10686","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T13:36:13Z","timestamp":1760276173000},"score":1,"resource":{"primary":{"URL":"https:\/\/acsjournals.onlinelibrary.wiley.com\/doi\/10.1002\/cncr.10686"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,7,31]]},"references-count":27,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2002,8,15]]}},"alternative-id":["10.1002\/cncr.10686"],"URL":"https:\/\/doi.org\/10.1002\/cncr.10686","archive":["Portico"],"relation":{},"ISSN":["0008-543X","1097-0142"],"issn-type":[{"value":"0008-543X","type":"print"},{"value":"1097-0142","type":"electronic"}],"subject":[],"published":{"date-parts":[[2002,7,31]]}}}